
Albemarle Corporation (NYSE:ALB – Free Report) – Research analysts at Scotiabank increased their Q3 2026 EPS estimates for Albemarle in a report released on Tuesday, October 27th. Scotiabank analyst B. Isaacson now expects that the specialty chemicals company will post earnings of $2.77 per share for the quarter, up from their previous estimate of $2.67. Scotiabank has a “Sector Outperform” rating and a $190.00 price objective on the stock. The consensus estimate for Albemarle’s current full-year earnings is $11.19 per share.
A number of other research analysts have also recently commented on the company. Argus dropped their price target on Albemarle from $230.00 to $135.00 and set a “buy” rating on the stock in a research report on Wednesday, October 7th. Jefferies Financial Group lowered their price objective on Albemarle from $244.00 to $211.00 and set a “buy” rating on the stock in a research note on Tuesday, June 30th. Rothschild & Co Redburn dropped their price objective on shares of Albemarle from $188.00 to $170.00 and set a “neutral” rating on the stock in a report on Wednesday, July 1st. Royal Bank Of Canada cut their target price on shares of Albemarle from $157.00 to $129.00 and set an “outperform” rating for the company in a research report on Thursday, October 15th. Finally, Wall Street Zen upgraded shares of Albemarle from a “hold” rating to a “buy” rating in a research note on Saturday, October 10th. Fifteen analysts have rated the stock with a Buy rating, seven have given a Hold rating and three have assigned a Sell rating to the company. According to data from MarketBeat, the stock presently has an average rating of “Hold” and an average price target of $179.41.
Read Our Latest Stock Report on Albemarle
Albemarle Price Performance
Shares of NYSE ALB opened at $99.05 on Wednesday. The stock has a fifty day simple moving average of $114.29 and a two-hundred day simple moving average of $150.86. Albemarle has a 1-year low of $88.01 and a 1-year high of $221.00.
Albemarle (NYSE:ALB – Get Free Report) last released its earnings results on Wednesday, August 5th. The specialty chemicals company reported $3.75 earnings per share for the quarter, beating analysts’ consensus estimates of $3.20 by $0.55. The company had revenue of $1.74 billion during the quarter, compared to analysts’ expectations of $1.61 billion. During the same quarter in the previous year, the firm earned $0.11 earnings per share. The firm’s revenue was up 31.1% compared to the same quarter last year.
Institutional Inflows and Outflows
A number of hedge funds have recently added to or reduced their stakes in the stock. BOKF NA raised its holdings in shares of Albemarle by 5,857.7% during the third quarter. BOKF NA now owns 11,558 shares of the specialty chemicals company’s stock valued at $1,223,000 after acquiring an additional 11,364 shares in the last quarter. Pinnacle Wealth Planning Services Inc. increased its position in shares of Albemarle by 23.2% during the third quarter. Pinnacle Wealth Planning Services Inc. now owns 2,175 shares of the specialty chemicals company’s stock valued at $230,000 after buying an additional 409 shares during the period. Asset Management One Co. Ltd. increased its position in shares of Albemarle by 4.8% during the third quarter. Asset Management One Co. Ltd. now owns 6,072 shares of the specialty chemicals company’s stock valued at $642,000 after buying an additional 278 shares during the period. Sigma Planning Corp increased its position in shares of Albemarle by 137.9% during the third quarter. Sigma Planning Corp now owns 5,267 shares of the specialty chemicals company’s stock valued at $557,000 after buying an additional 3,053 shares during the period. Finally, Probity Advisors Inc. raised its stake in Albemarle by 27.5% in the third quarter. Probity Advisors Inc. now owns 2,579 shares of the specialty chemicals company’s stock worth $273,000 after buying an additional 556 shares in the last quarter. Hedge funds and other institutional investors own 92.87% of the company’s stock.
Albemarle Announces Dividend
The business also recently announced a quarterly dividend, which will be paid on Monday, January 4th. Shareholders of record on Friday, December 18th will be paid a $0.41 dividend. The ex-dividend date is Friday, December 18th. This represents a $1.64 annualized dividend and a yield of 1.7%.
About Albemarle
Albemarle Corporation (NYSE: ALB) is a global specialty chemicals company headquartered in Charlotte, North Carolina. The company develops, manufactures, and markets engineered chemicals used in energy storage, transportation, refining, pharmaceuticals, agriculture, consumer products, and other industrial applications.
Albemarle is one of the world’s major producers of lithium and supplies lithium compounds, including lithium carbonate and lithium hydroxide, for use in rechargeable batteries for electric vehicles, portable electronics, and grid energy-storage systems.
Featured Articles
- Five stocks we like better than Albemarle
- Hidden in Plain Sight: 2 Earnings Winners Investors May Have Missed
- These 3 New ETFs Are Turning Heads—Are They Worth Buying?
- Coca-Cola Stock Is Everything AI Isn’t—And That’s Its Biggest Strength
- Apple’s Foldable iPhone Sold Out in Minutes, But Wall Street Has Questions
Receive News & Ratings for Albemarle Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Albemarle and related companies with MarketBeat.com's FREE daily email newsletter.
